We are live on ! Find out more
ZYME icon

Zymeworks

115 hedge funds and large institutions have $513M invested in Zymeworks in 2023 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 37 increasing their positions, 27 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 21

72% more call options, than puts

Call options by funds: $2.46M | Put options by funds: $1.43M

37% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 27

19% more funds holding

Funds holding: 97 → 115 (+18)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

3% less capital inflows, than outflows

Capital inflows: $69.7M | Capital outflows: $72.2M

2.72% less ownership

Funds ownership: 91.25% → 88.53% (-2.7%)

Holders
115
Holders Change
+18
Holders Change %
+18.56%
% of All Funds
1.83%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
39
Increased
37
Reduced
27
Closed
21
Calls
$2.46​M
Puts
$1.43​M
Net Calls
+$1.02​M
Net Calls Change
+$998​K

ZYME Hedge Fund Activity: Q1 2023 in Review

115 of the 6,286 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q1 2023, worth a combined $513M — up 13% from $452M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new ZYME positions and 21 closed out — a net gain of 18 holders — while 37 added to existing stakes and 27 trimmed.

The largest buyer was EcoR1 Capital, adding an estimated $22M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $13.4M sold.

  • 115 institutional investors held Zymeworks (ZYME) as of Q1 2023, up from 97 in Q4 2022.
  • Funds reported $513M of Zymeworks stock for Q1 2023, up 13% quarter-over-quarter.
  • 39 funds opened new Zymeworks positions in Q1 2023 and 21 closed out, a net change of +18 holders.
  • The largest Zymeworks buyer in Q1 2023 was EcoR1 Capital, an estimated $22M added.
  • The largest Zymeworks seller in Q1 2023 was Baker Bros. Advisors, an estimated $13.4M sold.

Based on aggregated 13F filings for Q1 2023.